Logo
C

Codexis, Inc.

253 employees

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolverĀ® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.

Investor insights

Funding rounds participated in

$40M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2002

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

C

Codexis, Inc. raised $40M on March 13, 2024

Investors: Innovatus Capital Partners

FAQ